Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTO 328 in Advanced or Metastatic Renal Cell Cancer
NCT00311545Phase 2Withdrawn
- Sponsor
- SWOG Cancer Research Network
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of siltuximab in renal cell carcinoma (RCC), sponsored by SWOG Cancer Research Network. Status: withdrawn.
02
Drugs
siltuximab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00311545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311545.